Involvement of kappa opioid receptors in formalin-induced inhibition of analgesic tolerance to morphine in mice

Journal of Pharmacy and Pharmacology

Volumn 59, Issue 8, 2007, Pages 1109-1115

  Tokuyama, Shogo ^a   Nagae, Ryuji ^a   Mashida, Emiko ^a   Hamabe, Wakako ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BINALTORPHIMINE; FORMALDEHYDE; KAPPA OPIATE RECEPTOR; MORPHINE; NALTRINDOLE; OLIGODEOXYNUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG TOLERANCE; DRUG USE; MALE; MOUSE; NONHUMAN; PAIN; REPEATED DRUG DOSE;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, OPIOID; ANIMALS; CHRONIC DISEASE; DRUG TOLERANCE; FORMALDEHYDE; MALE; MICE; MORPHINE; NALTREXONE; OLIGONUCLEOTIDES, ANTISENSE; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; TAIL;

EID: 34547958425     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.59.8.0008     Document Type: Article

References (38)

1. Chien, C. C., Brown, G., Pan, Y. X., Pasternak, G. W. (1994) Blockade of U50488H analgesia by antisense oligodeoxynucleotides to a k opioid receptor. Eur. J. Pharmacol. 253: R7-8
2. Daniels, D. J., Lenard, N. R., Etienne, C. L., Law, P. Y., Roerig, S. C, Portoghese, P. S. (2005) Opioid induced tolerance and dependence in mice is modulated by the distance between pharmacolphores in a bivalent ligand series, Proc. Natl. Acad. Sci. USA 102: 19208-19213
3. Devine, D. P., Leone, P., Pocock, D., Wise, R. A. (1993) Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in-vivo microdialysis studies. J. Pharmacol. Exp. Ther. 266: 1236-1246
4. Ellison, N. M. (1993) Opioid analgesics for cancer pain: toxicities and their treatment. In: Patt, R. B. (eds) Cancer pain. Philadelphia: JB Lippincott, pp 185-194
5. Fukunaga, H., Takahashi, M., Kaneto, H., Yoshikawa, M. (1999) Effects of Tyr MIF 1 on stress induced analgesia and the blockade of development of morphine tolerance by stress in mice. Jpn J. Pharmacol. 79: 231-235
6. Gray, A. C., Coupar, I. M., White, P. J. (2006) Comparison of opioid receptor distribution in the rat central nervous system. Life Sci. 79: 674-685
7. Haley, T. J., McCormick, W. G. (1957) Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. Chemother. 12: 12-15
8. Ilnytska, O., Lyzogubov, V. V., Stevens, M. J., Drel, V. R., Mashtalir, N., Pacher, P., Yorek, M. A., Obrosova, I. G. (2006) Poly(ADP ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy. Diabetes 55: 1686-1694
9. Iyengar, S., Webster, A. A., Hemrick Luecke, S. K., Xu, J. Y., Simmons, R. M. (2004) Efficacy of duloxetine, a potent and balanced serotonin norepinephrine reuptake inhibitor, in persistent pain models in rats. J. Pharmacol. Exp. Ther. 311: 576-584
10. Itoh, J., Ukai, M., Kameyama, T. (1994) Dynorphin A (1-13) potently improves the impairment of spontaneous alternation performance induced by the mu selective opioid receptor agonist DAMGO in mice. J. Pharmacol. Exp. Ther. 269: 15-21
11. Jamot, L., Matthes, H.W. D., Simonini, F., Kieffer, B. L., Roder, J. C. (2003) Differential involvement of the Mu and Kappa opioid receptors in spatial learning. Genes Brain Behav. 2: 80-92
12. Jang, S., Kim, H., Kim, D., Jeong, M. W., Ma, T., Kim, S., Ho, I. K., Oh, S. (2006) Attenuation of morphine tolerance and withdrawal syndrome by coadministration of nalbuphine. Arch. Pharm. Res. 29: 677-684
13. Javan, M., Ahmadiani, A., Motamedi, F., Kazwmi, B. (2005) Changes in G protein gene expression in rat lumbar spinal cord support the inhibitory effect of chronic pain on the development of tolerance to morphine analgesia. Neurosci. Res. 53: 250-256
14. Jordan, B. A., Devi, L. A. (1999) G protein coupled heterodimerization modulates receptor function. Nature 399: 697-700
15. Kieffer, B. L. (1995) Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell. Mol. Neurobiol. 15: 615-635
16. Kieffer, B. L., Evans, C. J. (2002) Opioid tolerance - in search of the Holy Grail. Cell 108: 587-590
17. Lee, S. C., Wang, J. J. Ho, S. T., Tao, P. L. (1997) Nalbuphine coadministered with morphine prevents tolerance and dependence. Anesth Analg 84: 810-815
18. McLaughlin, J. P., Li, S., Valdez, J., Chavkin, T. A., Chavlin, C. (2006) Social defeat stress induced behavioral responses are mediated by the endogeneous kappa opioid system. Neuropsychopharmacology 31: 1241-1248
19. Mochizucki, D. (2004) Serotonin and noradrenaline reuptake inhibitors in animal models of pain. Hum. Psychopharmacol. 19 Suppl 1: S15-19
20. Narita, M., Ozaki, S., Suzuki, T. (2002) Endomorphin induced motivational effect: differential mechanism of endomorphin 1 and endomorphin 2. Jpn J. Pharmacol. 89: 224-228
21. Narita, M., Kishimoto, Y., Ise, Y., Yajima, Y., Misawa, K., Suzuki, T. (2005) Direct evidence for the involvement of the mesolimbic kappa opioid system in the morphine induced rewarding effect under an inflammatory pain like state. Neuropsychopharmacology 30: 111-118
22. Pan, Z. Z. (1998) mu-Opposing actions of the kappa opioid receptor. Trends Pharmacol. Sci. 19: 94-98
23. Rahman, A. F., Takahashi, M., Kaneto, H. (1994) Involvement of pain associated anxiety in the development of morphine tolerance in formalin treated mice. Jpn J. Pharmacol. 65: 313-317
24. Randall, L. O. Selitto, J. J. (1957) A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. Ther. 111: 409-419
25. Reisine, T., Pasternak, G. (1996) Opioid analgesics and antagonists. In: Hardman, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, R. W. (eds) Goodman and Gilman's the pharmacological basis of therapeutics, 9th edn. New York: McGraw Hill, pp 521-555
26. Simmons, M. L., Chavkin, C. (1996) Endogenous opioid regulation of hippocampal function. Int. Rev. Neurobiol. 39: 145-196
27. Snook, L. A., Milligan, G., Kieffer, B. L., Massotte, D. (2006) Mu delta opioid receptor functional interaction: Insight using receptor G protein fusions. J. Pharmacol. Exp. Ther. 318: 683-690
28. Snyder, S. H., Pasternak, G. W. (2003) Historical review: Opioid receptors. Trends Pharmacol. Sci. 24: 198-205
29. Spanagel, R., Herz, A., Shippenberg, T. S. (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. USA 89: 2046-2050
30. Suzuki, S., Chuang, T. K., Chuang, L. F., Doi, R. H., Chuand, R. Y. (2001) Morphine upregulates kappa opioid receptors of human lymphocytes. Adv. Exp. Med. Biol. 493: 81-87
31. Suzuki, T. (2001) Modification of morphine dependence under chronic pain and its mechanism. Yakugaku Zasshi 121: 909-914
32. Suzuki, T., Narita, M., Takahashi, T., Misawa, M., Nagase, H. (1992) Effects of nor binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine. Eur. J. Pharmacol. 213: 91-97
33. Takahashi, M., Senda, T., Kaneto, H. (1991) Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine. Eur. J. Pharmacol. 200: 293-297
34. Takemori, A. E., Loh, H. H., Lee, N. M. (1993) Suppression by dynorphin A and [des Tyr1]dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine dependent mice. J. Pharmacol. Exp. Ther. 266: 121-124
35. Tao, P. L., Hwang, C. L., Chen, C. Y. (1994) U 50,488 blocks the development of morphine tolerance and dependence at a very low dose in guinea pigs. Eur. J. Pharmacol. 256: 281-286
36. Tao, P. L., Wu, S. C., Yang, C. H., Wu, C. C. (2000) Study the mechanisms of U50488H to prevent the development of morphine tolerance in guinea pigs. Chin. J. Physiol. 43: 179-184
37. Vaupel, D. B., Lange, W. B., London, E. D. (1993) Effects of verapamil on morphine induced euphoria, analgesia and respiratory depression in humans. J. Pharmacol. Exp. Ther. 267: 1386-1394
38. Vetulani, J. (2001) Drug addction. Part I. Psychoactive substances in the past and presence. Pol J Pharmacol. 53: 201-214